BI
GNCA

BVF Inc’s Genocea Biosciences, Inc. GNCA Stock Holding History

BVF Inc’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,012,404
Closed -$5.02M – 87
2022
Q1 		$5.02M Hold
4,012,404
– – 0.2% 66
2021
Q4 		$4.65M Hold
4,012,404
– – 0.17% 70
2021
Q3 		$7.7M Hold
4,012,404
– – 0.3% 61
2021
Q2 		$9.39M Hold
4,012,404
– – 0.35% 51
2021
Q1 		$10.9M Hold
4,012,404
– – 0.41% 46
2020
Q4 		$9.71M Hold
4,012,404
– – 0.38% 46
2020
Q3 		$9.19M Buy
4,012,404
+1,994,006
+99% +$5.23M 0.5% 45
2020
Q2 		$4.64M Sell
2,018,398
-81,907
-4% -$189K 0.29% 49
2020
Q1 		$3.61M Hold
2,100,305
– – 0.34% 44
2019
Q4 		$4.35M Hold
2,100,305
– – 0.33% 43
2019
Q3 		$6.09M Hold
2,100,305
– – 0.64% 40
2019
Q2 		$8.23M Buy
2,100,305
+1,121,775
+115% +$5.85M 0.9% 36
2019
Q1 		$4.62M Buy
978,530
+339,223
+53% +$1.68M 0.52% 43
2018
Q4 		$1.47M Sell
639,307
-18,818
-3% -$93.6K 0.19% 49
2018
Q3 		$4.11M Hold
658,125
– – 0.36% 47
2018
Q2 		$4.5M Buy
658,125
+33,125
+5% +$248K 0.44% 43
2018
Q1 		$5.25M Buy
+625,000
New +$5.19M 0.53% 36

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

BVF Inc's GNCA Position: Q2 2022 in Review

BVF Inc sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 4,012,404 shares — an estimated $5.02M sold.

BVF Inc first reported a position in GNCA in Q1 2018 and held it in 17 quarters. The position peaked at $10.9M in Q1 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

  • BVF Inc reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • BVF Inc sold 4,012,404 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $5.02M.
  • BVF Inc first reported a position in Genocea Biosciences, Inc. in Q1 2018 and held it in 17 quarters.
  • BVF Inc's Genocea Biosciences, Inc. position peaked at $10.9M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on BVF Inc's 13F filing for Q2 2022, filed 15 Aug 2022.